==== Front Signal Transduct Target Ther Signal Transduct Target Ther Signal Transduction and Targeted Therapy 2095-9907 2059-3635 Nature Publishing Group UK London 1508 10.1038/s41392-023-01508-2 Correction Author Correction: GPR162 activates STING dependent DNA damage pathway as a novel tumor suppressor and radiation sensitizer Long Yao 1234 Guo Jiaxing 1234 Chen Jielin 1234 Sun Jingyue 1234 Wang Haiyan 1234 http://orcid.org/0000-0003-0601-4991 Peng Xin 1234 Wang Zuli 1234 Lai WeiWei 1234 http://orcid.org/0000-0001-5162-3791 Liu Na 12345 Shu Long 1234 Chen Ling 1234 http://orcid.org/0000-0003-4671-4896 Shi Ying 1234 http://orcid.org/0000-0003-2204-5042 Xiao Desheng xdsh96@csu.edu.cn 1234 http://orcid.org/0000-0002-7206-7277 Liu Shuang shuangliu2016@csu.edu.cn 1234 http://orcid.org/0000-0003-2354-5321 Tao Yongguang taoyong@csu.edu.cn 1234 1 grid.452223.0 0000 0004 1757 7615 Department of Pathology, Key Laboratory of Carcinogenesis and Cancer Invasion(Ministry of Education), Xiangya Hospital, Central South University, Changsha, Hunan 410078 China 2 grid.216417.7 0000 0001 0379 7164 NHC Key Laboratory of Carcinogenesis of Ministry of Health (Central South University), Cancer Research Institute, School of Basic Medicine, Central South University, Changsha, Hunan 410078 China 3 grid.452223.0 0000 0004 1757 7615 Department of Pathology, Xiangya Hospital, Central South University, Changsha, Hunan 410008 China 4 grid.452708.c 0000 0004 1803 0208 Hunan Key Laboratory of Tumor Models and Individualized Medicine, Department of Thoracic Surgery, Second Xiangya Hospital, Central South University, Changsha, China 5 grid.452223.0 0000 0004 1757 7615 Hunan International Scientific and Technological Cooperation Base of Brain Tumor Research, Xiangya Hospital, Central South University, Changsha, Hunan 410008 China 30 6 2023 30 6 2023 2023 8 259© The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/ Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. Subject terms Cancer genetics Cell biology issue-copyright-statement© West China Hospital, Sichuan University 2023 ==== Body pmcCorrection to: Signal Transduction and Targeted Therapy (2023) 8:48 10.1038/s41392-022-01224-3, Published 1 February 2023 Since the publication of this article, we noticed a minor mistake in the article that needs to be corrected. We have checked the original data; the correct data are provided in this Corrigendum as follows. The key findings of the article are not affected by these corrections. In the original version of this article1, the photomicrograph showing a representative image of A549 cells treated with or without IR in Fig. 4a was incorrect. The image has now been corrected.Fig.1a We apologize for this inadvertent mistake. ==== Refs Reference 1. Long Y GPR162 activates STING dependent DNA damage pathway as a novel tumor suppressor and radiation sensitizer Signal Transduct Target Ther 2023 8 48 10.1038/s41392-022-01224-3 36725837